Date published: 2026-5-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

OR56A5 Inhibitors

OR56A5 inhibitors represent a class of chemical compounds specifically designed to modulate the activity of the OR56A5 receptor, a member of the olfactory receptor (OR) family. Olfactory receptors are G-protein-coupled receptors (GPCRs) predominantly expressed in the olfactory epithelium, where they play a central role in detecting odorants and initiating the olfactory signal transduction pathway. These receptors are highly specialized, capable of recognizing a broad array of volatile organic compounds. OR56A5, in particular, is associated with the detection of specific molecular structures, though its ligand profile remains to be fully elucidated. Inhibitors targeting OR56A5 function by obstructing the receptor's ability to bind with its ligands or by altering its conformation in such a way that it cannot activate the associated G-protein signaling pathway. This interference prevents the subsequent intracellular cascade typically involved in signal transmission.

The structural nature of OR56A5 inhibitors often involves molecules that can either occupy the receptor's ligand-binding domain or stabilize inactive conformations of the receptor. These inhibitors are typically characterized by their lipophilicity and specific molecular geometry, which allow them to interact with the hydrophobic regions of the receptor. Additionally, studies into the dynamics of GPCR-ligand interactions suggest that OR56A5 inhibitors may also influence receptor dimerization or oligomerization states, further modulating its functional activity. This selective inhibition can offer insights into the receptor's broader role in non-olfactory tissues, as olfactory receptors have been identified in other systems within the body, contributing to cellular processes unrelated to odor detection. Understanding the molecular mechanisms underlying OR56A5 inhibition can aid in the broader comprehension of GPCR function, receptor-ligand specificity, and the intricate chemical networks that govern receptor-mediated signal transduction.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$74.00
$243.00
$731.00
$2572.00
$21848.00
53
(3)

This antibiotic binds to DNA sequences and could downregulate OR56A5 by obstructing the transcription initiation complex.

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$41.00
$84.00
$275.00
127
(6)

By inhibiting the translocation step in eukaryotic translation, cycloheximide may lead to a decrease in OR56A5 protein synthesis.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

This immunosuppressant specifically binds to mTOR, which could result in the downregulation of the OR56A5 protein synthesis pathway.

Doxorubicin

23214-92-8sc-280681
sc-280681A
1 mg
5 mg
$176.00
$426.00
43
(3)

As an anthracycline antibiotic, doxorubicin intercalates DNA, which could inhibit the transcription of the OR56A5 gene.

Fluorouracil

51-21-8sc-29060
sc-29060A
1 g
5 g
$37.00
$152.00
11
(1)

This agent can be incorporated into RNA, leading to a decrease in functional OR56A5 mRNA and reduced protein levels.

Taxol

33069-62-4sc-201439D
sc-201439
sc-201439A
sc-201439E
sc-201439B
sc-201439C
1 mg
5 mg
25 mg
100 mg
250 mg
1 g
$41.00
$74.00
$221.00
$247.00
$738.00
$1220.00
39
(2)

Taxol (Paclitaxel) stabilizes microtubules, which may indirectly lead to the downregulation of OR56A5 expression by disrupting cell division and cellular signaling pathways.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

This histone deacetylase inhibitor could lead to hyperacetylation of histones, resulting in a more open chromatin structure and potentially decreased transcription of the OR56A5 gene.

α-Amanitin

23109-05-9sc-202440
sc-202440A
1 mg
5 mg
$269.00
$1050.00
26
(2)

By selectively inhibiting RNA polymerase II, α-amanitin could lead to a substantial reduction in OR56A5 mRNA synthesis.

Mithramycin A

18378-89-7sc-200909
1 mg
$55.00
6
(1)

Mithramycin A binds to DNA and could selectively inhibit the transcription of the OR56A5 gene by blocking promoter accessibility.

Triptolide

38748-32-2sc-200122
sc-200122A
1 mg
5 mg
$90.00
$204.00
13
(1)

This compound may inhibit the transcription of a wide range of genes, including OR56A5, by interacting with transcription factors.